Some studies on animals suggest that CBD could help to treat arthritis and relieve the associated inflammatory pain: A study found that. Can CBD Oil Treat Rheumatoid Arthritis Symptoms? Cannabidiol oil, also known as CBD oil, is a medicinal product derived from cannabis (marijuana). Researchers have recently starting focusing on CBD oil’s effects on several conditions that cause pain, including rheumatoid. CBD Oil for Arthritis Pain: Does It Relieve Symptoms? Cannabidiol oil, known as CBD oil or hemp oil, is all the rage these days, touted as a panacea for everything from cancer pain to depression and anxiety. CBD oil contains extracts from cannabis plants, which is the same plant.
help arthritis? How can CBD in
However, its effectiveness will vary from person to person. Work with your doctor to sort out the right balance of CBD oil, other medications, and self-care. This may work better than the medications you have been taking. We picked linked items based on the quality of products, and list the pros and cons of each to help you determine which will work best for you. We partner with some of the companies that sell these products, which means Healthline UK and our partners may receive a portion of revenues if you make a purchase using a link s above.
Article last updated by Yvette Brazier on Thu 2 August Visit our Osteoarthritis category page for the latest news on this subject, or sign up to our newsletter to receive the latest updates on Osteoarthritis. All references are available in the References tab. Preliminary assessment of the efficacy, tolerability and safety of a cannabis-based medication Sativex in the treatment of pain caused by rheumatoid arthritis [Abstract]. Rheumatology , 45 1 , 50— FDA approves first drug comprised of an active ingredient derived from marijuana to treat rare, severe forms of epilepsy [Press release].
European Journal of Pain , 20 6 , — Involvement of the endocannabinoid system in osteoarthritis pain [Abstract]. European Journal of Neuroscience , 39 3 , — Attenuation of early phase inflammation by cannabidiol prevents pain and nerve damage in rat osteoarthritis [Abstract].
Pain , 10 , Cannabinoids in the management of difficult to treat pain. Therapeutics and Clinical Risk Management , 4 1 , — The abnormal cannabidiol analogue O reduces nociception in a rat model of acute arthritis via the putative cannabinoid receptor GPR55 [Abstract]. Neuroscience Letters , 1 , 72— MNT is the registered trade mark of Healthline Media. Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a healthcare professional.
Sign in Log in with your Medical News Today account to create or edit your custom homepage, catch-up on your opinions notifications and set your newsletter preferences. Register for a free account Sign up for a free Medical News Today account to customize your medical and health news experiences. Register take the tour. Table of contents What is CBD oil? CBD oil is the oil derived from hemp, which is a type of cannabis plant.
Please use one of the following formats to cite this article in your essay, paper or report: If no author information is provided, the source is cited instead. Latest news Simple drug formula regenerates brain cells. Scientists have shown how a drug cocktail of four compounds can convert glia, or support cells, next to damaged neurons into new working neurons.
Breast cancer screening saved over 27, lives in A new study estimates that breast cancer mortality rates have fallen by approximately half in the United States in , thanks to screening and therapy. A step toward better treatment? Current treatments for alcohol use disorder are unsatisfactory, but recent research points toward a new intervention that may also benefit mood disorders.
What role does the gut play in Parkinson's disease? A review of existing research has examined the evidence for a connection between the gastrointestinal system and the progression of Parkinson's disease.
How important is eating breakfast? Intravital microscopy was used to assess leukocyte-endothelial interactions within the microcirculation of the knee joint, as described previously. In vivo leukocyte staining was achieved by intravenous administration of 0. Two measures of leukocyte-endothelial interactions were used to assess articular inflammation: Rolling leukocytes were defined as positively stained blood cells travelling slower than the surrounding blood flow, and adherent leukocytes were defined as positively stained cells that remained stationary for a minimum of 30 seconds.
At each time point, 1-minute recordings of the exposed knee joint were taken at a working distance of 10 cm with a frame capture rate of 25 images per second. At the end of the experiment, rats were euthanised and a dead scan of the knee was taken.
Images were analysed offline where mean blood perfusion perfusion units in a defined region of interest approximating the knee joint was calculated. Inflammation measures were conducted on day 1 post-MIA induction, which corresponds to the peak of inflammation in this OA model. Subsequent recordings were taken at 5, 15, 30, 60, , and minutes after drug administration.
A segment of the saphenous nerve was isolated proximal to the ipsilateral knee joint and placed in 2. The nerve samples were then removed from the fixative and rinsed 3 times with 0.
Epon—araldite resin was used to mount the samples. The samples were placed in a 3: Finally, using an LKB Huxley ultramicrotome with a diamond knife, the samples were sectioned into nm thick slices. The microscope was set at a voltage of One nerve cross-section image was visually partitioned into 9 quadrants and 3 images were captured from quadrants 1, 5, and 9.
All fibres were assessed using the G-ratio plugin in ImageJ processing software. The G-ratio was calculated using the equation where, a is the internal axonal area and A is the total axonal area of the fibre. The higher the G-ratio the higher the degree of demyelination. Cannabidiol 2-[ 1 R ,6 R methyl 1-methylethenyl cyclohexenyl]pentyl-1,3-benzenediol was obtained from Tocris Bioscience Bio-Techne, Abingdon, United Kingdom. AM CB 1 receptor antagonist; 1- 2,4-dichlorophenyl 4-iodophenyl methyl-Nmorpholinyl-1H-pyrazolecarboxamide and AM CB 2 receptor antagonist; 6-iodomethyl 2-morpholinylethyl indolyl]- 4-methoxyphenyl methanone were obtained from Cayman Chemicals Ann Arbor, MI.
Data were tested for Gaussian distribution by the Kolmogorov—Smirnov test. A P value less than 0. A total of 17 afferent fibres were recorded in this study. On days 14 to 19 post-MIA induction, close i. Example of a single-unit recording whereby CBD attenuated firing evoked by noxious rotation A.
The dose-dependent effect of CBD treatment on afferent firing rate was averaged over the 15 minutes after administration C. Effect of contralaterally administered CBD on ipsilateral pain behaviour. Contribution of cannabinoid and noncannabinoid receptors to the analgesic effects of CBD. One day after i. Contribution of cannabinoid and noncannabinoid receptors to the anti-inflammatory effects of CBD.
Pain and disease progression are poorly managed in many patients with OA because of the multifactorial nature of the disease. Intra-articular injection of MIA produces monoarthritis with several features that resemble human OA, including joint pain, intermittent inflammation, and joint nerve damage. This study aimed to address, for the first time, whether the inflammatory and neuropathic pain associated with MIA could be blocked by local administration of the noneuphoria producing phytocannabinoid CBD.
It has previously been shown that the pain associated with the MIA model of OA is mediated in part by the sensitisation of joint afferent fibres. These electrophysiology data confirm that CBD has a peripheral site of action in knee joints. These observations, along with our electrophysiology data, assert that CBD acts locally in the joint to reduce joint mechanical pain as revealed by improved weight bearing as well as a reduction in centrally mediated secondary allodynia as determined by hind paw withdrawal threshold.
Contralateral injection of CBD had no discernible effect on ipsilateral secondary allodynia confirming that the analgesic effect of intra-articular CBD was localised to the site of administration for this pain test. This may be because electrophysiology is a highly sensitive technique that detects subtle response to test agents in the periphery, whereas pain behaviours are more complex and encompass the entire pain pathway. The rationale for using two pain behavioural tests in this study was to interrogate different aspects of the pain pathway.
Dynamic incapacitance is a measure of spontaneous pain that is associated with joint degeneration or inflammation arising from peripheral sensitisation. Thus, it seems that local injection of CBD is effective at reducing direct nociceptive and inflammatory pain in the joint as well as ameliorating neuropathic features of OA pain. Both CB 1 and CB 2 receptor antagonists failed to block the CBD-mediated improvements in hind paw withdrawal threshold and weight bearing. Although CBD has been shown to act as an inverse agonist at CB 2 receptors and a full antagonist at CB 1 receptors, 40 it has also been shown to act through GPR55, serotonin receptors eg, 5-HT 1A , and various transient receptor potential ion channels.
Transient receptor potential vanilloid-1 is known to be involved in MIA-induced peripheral sensitisation, 17 therefore, antagonist experiments were performed to test the involvement of this ion channel in CBD-mediated analgesia. This mechanism of action has been previously reported in in vitro studies using human embryonic kidney HEK cells and using cell membranes from mouse and rat brains.
Cannabidiol has been shown to inhibit fatty acid amide hydrolase FAAH and the uptake of anandamide. Intra-articular injection of MIA produced an acute inflammatory response on day 1 after injection. This acute phase of inflammation was evinced by an increase in leukocyte trafficking and a moderate increase in joint blood flow. Local application of CBD significantly reduced these acute, inflammatory changes corroborating what has previously been reported in other inflammatory models.
Opening of TRPV1 ion channels causes the peripheral release of inflammatory neuropeptides which promote neurogenic inflammation and enhanced leukocyte trafficking in joints.
A central hypothesis of this study was that early inhibition of OA-related inflammation with CBD would reduce the development of persistent joint pain. Prophylactic treatment of OA joints with CBD on days 1 to 3 after MIA induction prevented secondary allodynia at day 14, but had no effect on hind limb weight bearing.
Inflammation associated with MIA diminishes by day 7, 4 therefore the pain associated with end-stage OA in this model is largely due to joint degeneration and peripheral neuropathy. Thus, by abolishing early inflammation with prophylactic treatment, CBD attenuates central sensitisation and neuropathic pain development in OA. The G-ratio data would benefit from future studies examining the expression of a biomarker for peripheral nerve damage to further support this finding.
Several cannabis compounds, including CBD, have been shown to be neuroprotective in other musculoskeletal disorders.
In a preclinical model of multiple sclerosis, CBD was shown to improve clinical recovery and rotarod scores in animals, correlating with and indicative of a neuroprotective effect. Cannabidiol is a noneuphoria producing compound and has a more desirable side effect profile compared with other cannabinoid compounds and commonly prescribed analgesics.
Animal studies where CBD was administered systemically showed that the animals had no signs of adverse side effects. Successful relief of OA symptoms by peripherally administered CBD suggests a therapeutic option that has a low chance of adverse effects which is more desirable for patients.
This study showed for the first time that local CBD administration inhibited pain and peripheral sensitisation in established OA. By attenuating this initial inflammatory response with CBD, end-stage OA pain and peripheral neuropathy were abrogated. Thus, CBD may be a safe therapeutic to treat OA pain locally as well as block the acute inflammatory flares that drive disease progression and joint neuropathy.
All experimental protocols were approved by the Dalhousie University Committee on Laboratory Animals, which acts in accordance with the standards put forth by the Canadian Council for Animal Care. Availability of data and materials: Philpott conducted the pain behaviour experiments, the inflammation measurements IVM and LASCA , performed the G-ratio measurements, analysed data, and helped draft the manuscript.
O'Brien conducted all electrophysiology experiments, analysed the data, and helped draft the manuscript. McDougall conceived the study, participated in its design and coordination, helped analyse data, and helped draft the manuscript. All authors read and approved the final manuscript. Sponsorships or competing interests that may be relevant to content are disclosed at the end of this article. National Center for Biotechnology Information , U. Published online Sep 1. Author information Article notes Copyright and License information Disclaimer.
Published by Wolters Kluwer Health, Inc. The work cannot be changed in any way or used commercially without permission from the journal.
This article has been cited by other articles in PMC. Abstract Osteoarthritis OA is a multifactorial joint disease, which includes joint degeneration, intermittent inflammation, and peripheral neuropathy. Cannabinoids, Osteoarthritis, Pain, Neuropathy, Inflammation. Introduction The most prominent form of synovial joint disease, osteoarthritis OA , is characterised by joint degeneration, pain, and in some patients, articular neuropathy.
Experimental timeline On day 14 post-MIA induction, 3 sets of noxious rotations, each lasting 5 seconds, were applied 5 minutes apart as a baseline measurement of afferent activity. Behavioural pain measurements 2. Von Frey hair mechanosensitivity Von Frey hair mechanosensitivity was used as a measure of secondary allodynia.
Intravital microscopy Both hind limbs were immobilised and the capsule of the ipsilateral knee was exposed by surgically removing a small ellipse of the overlying skin and superficial fascia.
Experimental timeline Inflammation measures were conducted on day 1 post-MIA induction, which corresponds to the peak of inflammation in this OA model. G-ratio analysis of the saphenous nerve A segment of the saphenous nerve was isolated proximal to the ipsilateral knee joint and placed in 2.
Drugs and reagents Cannabidiol 2-[ 1 R ,6 R methyl 1-methylethenyl cyclohexenyl]pentyl-1,3-benzenediol was obtained from Tocris Bioscience Bio-Techne, Abingdon, United Kingdom. Effect of acute administration of cannabidiol on joint afferent mechanosensitivity A total of 17 afferent fibres were recorded in this study. Table 1 Characterisation of the recorded fibres in the electrophysiology experiments.
Open in a separate window. Effect of acute administration of cannabidiol on sodium monoiodoacetate—induced inflammation One day after i. Discussion Pain and disease progression are poorly managed in many patients with OA because of the multifactorial nature of the disease. Conclusions This study showed for the first time that local CBD administration inhibited pain and peripheral sensitisation in established OA.
Conflict of interest statement The authors have no conflicts of interest to declare. This work was supported by an operating grant provided by The Arthritis Society. Acknowledgements The technical assistance of Allison Reid is gratefully acknowledged. Footnotes Sponsorships or competing interests that may be relevant to content are disclosed at the end of this article. Use of the painDETECT tool in rheumatoid arthritis suggests neuropathic and sensitization components in pain reporting.
J Pain Res ; 7: Leukocyte trafficking and pain behavioral responses to a hydrogen sulfide donor in acute monoarthritis.
Molecular targets for cannabidiol and its synthetic analogues: Br J Pharmacol ; Weight bearing as a measure of disease progression and efficacy of anti-inflammatory compounds in a model of monosodium iodoacetate-induced osteoarthritis. Osteoarthr Cartil ;
Can CBD oil relieve arthritis pain?
The cannabis activates the pathways to those important CB2 receptors and may help control the pain. Patients with rheumatoid arthritis. Some preliminary research suggests that CBD may help with arthritis pain. In animal studies, which may not translate to humans, CBD relieved arthritis pain and. Learn how to use marijuana for arthritis, as well as the best strains to use, and get a simplified How exactly can cannabis help with arthritis.